A Milestone-Based Framework for Characterizing Time-Varying Treatment Effects in Immunotherapy Trials

Yi-Cheng Tai, Weijing Wang, Jedd D. Wolchok +1

Immune checkpoint inhibitor--based therapies often produce heterogeneous survival responses, including early risk, delayed treatment benefit, and durable long-term survival in a su…